Inventor
Mark R. Bray
Inventor
Oakville, CA
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes32%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
C07DHeterocyclic compounds26%
C07KPeptides5%
C12NMicroorganisms or enzymes5%
PatentTitleYear
10,875,863RIPK2 inhibitors and method of treating cancer with same202010,239,881RIPK2 inhibitors and method of treating cancer with same20199,642,856'Treatment for pancreatic cancer'20179,555,042'Treatment for pancreatic cancer'20178,114,870'Method of treating disease states using substituted pyrazole compounds'20127,713,915'Cytotoxic heteromeric protein combinatorial libraries'20107,563,787'Substituted pyrazole compounds'2009Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2009–2012Patents assigned to MIIKANA THERAPEUTICS INC (2)· patent assignee history
2009–2020Based in Oakville, CA· patent location history
2010Patents assigned to MOLECULAR TEMPLATES INC (1)· patent assignee history
2010Based in Toronto, CA· patent location history
2012Patents assigned to AGOSTON GREGORY E (1)· patent assignee history
2012Patents assigned to BRAY MARK R (1)· patent assignee history
2017–2020Patents assigned to UNIV HEALTH NETWORK (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV HEALTH NETWORK | 3 | 2017–2020 |
| MIIKANA THERAPEUTICS INC | 2 | 2009–2012 |
| AGOSTON GREGORY E | 1 | 2012 |
| BRAY MARK Rself | 1 | 2012 |
| MOLECULAR TEMPLATES INC | 1 | 2010 |
Locations
| Location | Patents | Span |
|---|---|---|
| Oakville, CA | 6 | 2009–2020 |
| Toronto, CA | 1 | 2010 |